Factors impeding organ recovery despite a deep haematological response in patients with systemic <scp>AL</scp> amyloidosisAndrew Staron, Vaishali Sanchorawala, Natasha Burke et al.|British Journal of Haematology|2024Cited by 7
Machine‐learning based subgroups of <scp>AL</scp> amyloidosis and cumulative incidence of mortality and end stage kidney diseaseShankara Anand, Ashish Verma, Vaishali Sanchorawala et al.|American Journal of Hematology|2024Cited by 7
Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollmentVaishali Sanchorawala, Andrew Staron, Anthony C Shelton et al.|Blood Advances|2024Cited by 1
Machine Learning-Based Clustering Identifies Novel Subgroups of Patients with AL Amyloidosis with Distinct Clinical Characteristics PA2 (#69)Shankara Anand, Ashish Verma, Andrew Staron et al.|Unknown|2024Cited by 0
Clinical Factors Associated with Early Sudden Unexpected Death in Systemic AL Amyloidosis: Insights from 138 Cases OA11 (#209)Andrew Staron, Vaishali Sanchorawala, Luke Zheng et al.|Unknown|2024Cited by 0